DE3585497D1 - Hypercholesterolemisch aktive produkte. - Google Patents

Hypercholesterolemisch aktive produkte.

Info

Publication number
DE3585497D1
DE3585497D1 DE8585307945T DE3585497T DE3585497D1 DE 3585497 D1 DE3585497 D1 DE 3585497D1 DE 8585307945 T DE8585307945 T DE 8585307945T DE 3585497 T DE3585497 T DE 3585497T DE 3585497 D1 DE3585497 D1 DE 3585497D1
Authority
DE
Germany
Prior art keywords
hypercholesterolemically
active products
products
active
hypercholesterolemically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585307945T
Other languages
English (en)
Inventor
Yasuo Kawai
Kazunaga Yazawa
Hirotaka Shimohashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advance KK
Original Assignee
Advance KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance KK filed Critical Advance KK
Application granted granted Critical
Publication of DE3585497D1 publication Critical patent/DE3585497D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8585307945T 1984-11-05 1985-11-01 Hypercholesterolemisch aktive produkte. Expired - Fee Related DE3585497D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59231266A JPS61109729A (ja) 1984-11-05 1984-11-05 コレステロ−ル低下剤

Publications (1)

Publication Number Publication Date
DE3585497D1 true DE3585497D1 (de) 1992-04-09

Family

ID=16920911

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585307945T Expired - Fee Related DE3585497D1 (de) 1984-11-05 1985-11-01 Hypercholesterolemisch aktive produkte.

Country Status (3)

Country Link
EP (1) EP0181170B1 (de)
JP (1) JPS61109729A (de)
DE (1) DE3585497D1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61271223A (ja) * 1985-05-24 1986-12-01 Biofuerumin Seiyaku Kk 血中脂質改善剤
JPH0696537B2 (ja) * 1986-05-02 1994-11-30 雪印乳業株式会社 血清コレステロ−ル上昇抑制剤
DE3885468T2 (de) * 1987-07-09 1994-02-24 Kabushikikaisya Advance Tokio Mittel zur verringerung des lipidperoxidgehaltes.
JP2764267B2 (ja) * 1988-04-20 1998-06-11 雪印乳業株式会社 胆汁酸分泌促進作用を有する機能性飲食品
FR2654587B1 (fr) * 1989-11-20 1992-12-11 Dolisos Lab Produit a base de levures dietetiques permettant d'obtenir un meilleur equilibre des fonctions organiques humaines et animales.
US6479050B1 (en) * 1991-06-03 2002-11-12 Innovi N.V. Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
FR2740471B1 (fr) * 1995-10-31 1997-12-19 Gervais Danone Co Ferments lactiques, et leur utilisation pour l'obtention de produits hypocholesterolemiants
CA2271930C (en) * 1996-11-29 2006-10-17 Bio K + International Inc. Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
EP1728855A1 (de) * 1996-11-29 2006-12-06 Bio-K Plus International, Inc. Milchsäureferment das einen speziellen Stamm von Lactobacillus acidophilus enthält und Verwendung davon
FR2831395B1 (fr) * 2001-10-25 2004-06-11 Triballat Laiteries Procede de fabrication de produits fermentes a base de soja, produits fermentes obtenus par ce procede et ferments correspondants
CN1244686C (zh) * 2003-06-20 2006-03-08 上海光明乳业股份有限公司 干酪乳杆菌lc2w菌株及其在制备抗高血压产品中的应用
JP2010100663A (ja) * 2003-08-26 2010-05-06 Toyo Shinyaku Co Ltd タマネギ発酵物を含有する酵素阻害剤
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
GB0424552D0 (en) * 2004-11-05 2004-12-08 Cambridge Theranostics Ltd Methods and means
BRPI0611492B1 (pt) 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
BRPI0615785B8 (pt) * 2005-09-08 2021-05-25 Yakult Honsha Kk composição inibidora da absorção de colesterol compreendendo bactérias do gênero bifidobacterium
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
RU2373957C2 (ru) 2006-10-13 2009-11-27 Александр Метталинович Тишин Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его
ES2551719T3 (es) 2007-02-01 2015-11-23 Iams Europe B.V. Procedimiento para disminuir la inflamación y el estrés en un mamífero usando antimetabolitos de glucosa, aguacate o extractos de aguacate
JP2008195673A (ja) * 2007-02-14 2008-08-28 Nippon Meat Packers Inc 延命効果物質、および感染防御効果・ワクチン効果促進物質、前記物質の検定用コンストラクト、並びにそれらの用途
US20090141690A1 (en) * 2007-10-01 2009-06-04 Qualcomm Incorporated Method and apparatus for uplink control signaling
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
JP5140791B2 (ja) * 2008-11-27 2013-02-13 森下仁丹株式会社 乳酸菌含有血中ホモシステイン低減剤
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2308499A1 (de) * 2009-09-30 2011-04-13 Nestec S.A. Bifidobacterium longum ATCC BAA-999 (BL999) und Gewichtskontrolle
WO2013084971A1 (ja) * 2011-12-07 2013-06-13 カルピス株式会社 乳酸菌又はその処理物を含む脂質代謝及び/又は糖代謝改善剤
JP5804579B2 (ja) * 2013-12-26 2015-11-04 雪印メグミルク株式会社 加齢に伴う代謝異常疾患の予防・改善・治療剤
GB201514303D0 (en) 2015-07-16 2015-09-23 Dupont Nutrition Biosci Aps Bifidobacteria for treating cardiac conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB930107A (en) * 1960-01-11 1963-07-03 Giuseppe Carlo Sigurta Therapeutic oral preparation of micro-organisms
FR3614M (fr) * 1965-07-01 1965-10-18 Carlo Giuseppe Sigurta Compositions anhydres, stables de lactobacilles, levures-streptocoques et quelques autres especes de bacilles et leur procédé de préparation.
FR5601M (de) * 1966-04-01 1967-12-11
DE2134179A1 (de) * 1971-07-09 1973-01-25 Rolf Dr Schuler Bifidobakterien enthaltendes praeparat und verfahren zur herstellung desselben
DE2421084A1 (de) * 1974-05-02 1975-11-20 Solco Basel Ag Idfidobakterien enthaltendes praeparat
FR2411008A1 (fr) * 1977-12-09 1979-07-06 Morinaga Milk Industry Co Ltd Composition en poudre comprenant une poudre contenant des cellules viables de bifidobacterium et une poudre contenant du lactulose

Also Published As

Publication number Publication date
JPS61109729A (ja) 1986-05-28
EP0181170A2 (de) 1986-05-14
EP0181170A3 (en) 1988-03-16
EP0181170B1 (de) 1992-03-04

Similar Documents

Publication Publication Date Title
DE3585497D1 (de) Hypercholesterolemisch aktive produkte.
DE3582636D1 (de) Ueberzogene produkte.
FI862128A (fi) Individuell parkeringsmaetare.
ES296010Y (es) Estanteria.
FI854020L (fi) Stol.
DE3675222D1 (de) Lageraufbau.
FI875217A (fi) Aktivt pansar.
FI860122A (fi) Flat paneldisplayenhet utnyttjande en linjeformad faeltemissionskatodgrupp.
FI875167A (fi) Kallvalsad bandstaolprodukt.
FI851910A0 (fi) Aromatiska oligomerer.
FI850150L (fi) Form foer en likriktad seismisk spaorparameter.
DE3674976D1 (de) Lageraufbau.
FI852658A0 (fi) Farmaceutiska aemnen.
FI853226A0 (fi) Antibiotika.
FI860471A (fi) N-substituerade butyramidderivat.
FI883254A (fi) Cytostatiskt aktiva antracyklinderivat.
FI853814A0 (fi) Surmjoelksprodukt.
FI883253A (fi) Cytostatiskt aktiva antracyklinderivat.
FI843181A0 (fi) Stegloes kuggvaexel. no = 842881a
FI843191A0 (fi) Automatisk momentfrikoppling. no = 842942a
ATE30555T1 (de) Anzeigeanordnung.
NO862000L (no) Individuelt parkometer.
KR860001023U (ko) P. c. b 지지구
FI841454A0 (fi) Baot bjoern.
FI842101A0 (fi) Farmaceutiskt oegonmedicinsammansaettning foer lokal behandling av intraokulaert tryck.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee